EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 35 / No 5 (Mai 2019) Med Sci (Paris), 35 5 (2019) 412-416 References
Open Access
Issue
Med Sci (Paris)
Volume 35, Number 5, Mai 2019
Page(s) 412 - 416
Section Le Magazine
DOI https://doi.org/10.1051/medsci/2019088
Published online 22 May 2019
  1. Dubocovich ML, Delagrange P, Krause DN, et al. International union of basic and clinical pharmacology. LXXV. Nomenclature, classification, and pharmacology of G protein-coupled melatonin receptors. Pharmacol Rev. 2010 ; 62 : 343–380. [CrossRef] [PubMed] [Google Scholar]
  2. Jockers R, Delagrange P, Dubocovich ML, et al. Update on melatonin receptors: IUPHAR Review 20. Br J Pharmacol. 2016 ; 173 : 2702–2725. [CrossRef] [PubMed] [Google Scholar]
  3. Bonnefond A, Clement N, Fawcett K, et al. Rare MTNR1B variants impairing melatonin receptor 1B function contribute to type 2 diabetes. Nat Genet. 2012 ; 44 : 297–301. [Google Scholar]
  4. Bouatia-Naji N, Bonnefond A, Froguel P. Avancées dans la génétique de la glycémie à jeun : quelles leçons pour le diabète ?. Med Sci (Paris). 2009 ; 25 : 897–902. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  5. Cipolla-Neto J, Amaral FG, Afeche SC, et al. Melatonin, energy metabolism, and obesity: a review. J Pineal Res. 2014 ; 56 : 371–381. [CrossRef] [PubMed] [Google Scholar]
  6. O’Brien IA, Lewin IG, O’Hare JP, et al. Abnormal circadian rhythm of melatonin in diabetic autonomic neuropathy. Clin Endocrinol (Oxf). 1986 ; 24 : 359–364. [Google Scholar]
  7. Scheer FA, Hilton MF, Mantzoros CS, Shea SA. Adverse metabolic and cardiovascular consequences of circadian misalignment. Proc Natl Acad Sci USA. 2009 ; 106 : 4453–4458. [CrossRef] [Google Scholar]
  8. Knutson KL, Ryden AM, Mander BA, Van Cauter E. Role of sleep duration and quality in the risk and severity of type 2 diabetes mellitus. Arch Intern Med. 2006 ; 166 : 1768–1774. [CrossRef] [PubMed] [Google Scholar]
  9. Karamitri A, Vincens M, Chen M, Jockers R. Implication des mutations du récepteur de la mélatonine MT2 dans la survenue du diabète de type 2. Med Sci (Paris). 2013 ; 29 : 778–784. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  10. Karamitri A, Jockers R. Melatonin in type 2 diabetes mellitus and obesity. Nat Rev Endocrinol. 2019 ; 15 : 105–125. [PubMed] [Google Scholar]
  11. Karamitri A, Plouffe B, Bonnefond A, et al. Type 2 diabetes-associated variants of the MT2 melatonin receptor affect distinct modes of signaling. Sci Signal. 2018 ; 11 : 545. [Google Scholar]
  12. Katsonis P, Lichtarge O. A formal perturbation equation between genotype and phenotype determines the evolutionary action of protein-coding variations on fitness. Genome Res. 2014 ; 24 : 2050–2058. [CrossRef] [PubMed] [Google Scholar]
  13. Karamitri A. JR. Exon sequencing of G protein-coupled receptor genes and perspectives for disease treatment. In: Stevens C, eds. G protein-coupled receptor genetics. Protocols methods in pharmacology and toxicology. New York : Springer, 2014 : 313–32. [Google Scholar]
  14. Poirel VJ, Masson-Pevet M, Pevet P, Gauer F. MT1 melatonin receptor mRNA expression exhibits a circadian variation in the rat suprachiasmatic nuclei. Brain Res. 2002 ; 946 : 64–71. [CrossRef] [PubMed] [Google Scholar]
  15. Beesley S, Lee J, Olcese J. Circadian clock regulation of melatonin MTNR1B receptor expression in human myometrial smooth muscle cells. Mol Hum Reprod. 2015 ; 21 : 662–671. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.